Toward precision medicine: can neuroimaging prospectively predict early treatment outcomes in schizophrenia spectrum disorders? A systematic review and meta-analysis.

Authors

Claudio Caiazza, Giancarlo Fusco, Lorenzo Ugga, Flavia Rossano, Claudia Toni, Mario Cirillo, Gaia Sampogna, Andrea Fiorillo

Published in

European archives of psychiatry and clinical neuroscience. Sep 06, 2026. Epub Sep 06, 2026.

Abstract

Variability in antipsychotic response results from interaction of illness-related, treatment-related, environmental factors, and intrinsic interindividual differences that have not yet been addressed. Since early non-response may predict later non-response, biomarkers capable of identifying individuals at higher risk of treatment failure may have important implications for management personalization. This study aimed to evaluate whether baseline neuroimaging can predict subsequent treatment outcomes in Schizophrenia-spectrum Disorders.
A systematic search of PubMed/EMBASE/IEEE Xplore was conducted until 04/20/2026, in accordance with PRISMA-DTA guidelines and a pre-registered protocol. Prospective studies using Magnetic Resonance Imaging/Positron Emission Tomography with predictive models for subsequent treatment outcomes were included. A random-effects multi-level meta-analysis was performed to pool areas under the curve (AUC). Hierarchical summary receiver operating characteristic (HSROC) curves estimated sensitivity/specificity. QUADAS-2 assessed Risk-of-bias.
Sixteen studies were included. The overall pooled discriminatory performance of multi-level hierarchical models was good (AUC = 0.75,95%C.I.[0.70-0.80],τ²=0.071,I² = 28.1%,k = 50,n = 14), best-AUC model showed similar, slightly better results (AUC = 0.81,95%C.I.[0.76-0.85],τ²=0.053,I²=21%,k = 11). Functional connectivity-based models showed the highest performance, significantly higher than activity/metabolism-based, structural models, at the Q-test statistics (p = 0.03). Baseline drug status and clinical stage did not significantly moderate estimates. The HSROC model yielded a sensitivity = 0.75,95%C.I.[0.68-0.79], specificity = 0.75,95%C.I.[0.67-0.81].
Baseline neuroimaging may provide relevant prognostic information in Schizophrenia Spectrum, especially based on functional connectivity, supporting that treatment response may be related to disturbances in large-scale network organization than to isolated structural abnormalities. These findings support the potential of prognostic neuroimaging in precision psychiatry and early-risk stratification. However, methodological standardization, external validation, and geographically-diverse samples remain necessary before a full clinical translation.

PMID:
42701990
Bibliographic data and abstract were imported from PubMed on 07 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.